​

TriSalus Life Sciences (TLSI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TLSI Stock Forecast

TriSalus Life Sciences (TLSI) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $11.00, with a high of $12.00 and a low of $8.00. This represents a 211.61% increase from the last price of $3.53.

$3 $4 $5 $6 $7 $8 $9 $10 $11 $12 High: $12 Avg: $11 Low: $8 Last Closed Price: $3.53

TLSI Stock Rating

TriSalus Life Sciences stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

TLSI Price Target Upside V Benchmarks

TypeNameUpside
StockTriSalus Life Sciences211.61%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks9.18%

Price Target Trends

1M3M12M
# Anlaysts-45
Avg Price Target-$11.75$11.00
Last Closing Price$3.53$3.53$3.53
Upside/Downside-232.86%211.61%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 2614---5
Oct, 2614---5
Sep, 2613---4
Aug, 2613---4
Jul, 2614---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 23, 2026Guggenheim$12.00$4.93143.41%239.94%
Sep 23, 2026H.C. Wainwright$12.00$4.93143.41%239.94%
Sep 09, 2026Swayampakula RamakanthH.C. Wainwright$11.00$4.73132.56%211.61%
May 13, 2026Lake Street$8.00$2.37237.55%126.63%
Nov 15, 2024William PlovanicCanaccord Genuity$11.00$4.11167.64%211.61%
Sep 16, 2024Suraj KaliaOppenheimer$10.00$4.52121.24%183.29%
Jul 02, 2024William PlovanicCanaccord Genuity$12.00$5.33125.14%239.94%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 23, 2026H.C. WainwrightBuyBuyhold
Sep 09, 2026H.C. WainwrightBuyinitialise
Nov 15, 2024Canaccord GenuityBuyBuyhold
Sep 16, 2024OppenheimerOutperforminitialise
Jul 02, 2024Canaccord GenuityBuyBuyhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.23$-1.25$-1.84---
Avg Forecast$-2.29$-1.26$-0.52$-0.32$0.19$0.52
High Forecast$-2.19$-1.23$-0.16$0.80$1.12$0.55
Low Forecast$-2.42$-1.30$-0.86$-0.97$-0.46$0.50
Surprise %-2.62%-0.79%253.85%---

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$18.51M$29.43M$45.15M---
Avg Forecast$18.24M$29.24M$44.98M$68.26M$94.14M$117.21M
High Forecast$19.06M$29.27M$45.68M$68.26M$98.38M$122.48M
Low Forecast$17.63M$29.20M$43.92M$68.26M$90.97M$113.26M
Surprise %1.47%0.64%0.39%---

Net Income Forecast

$-70M $-53M $-36M $-19M $-2M $15M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-59.36M$-33.23M$-69.69M---
Avg Forecast$-21.52M$-11.89M$-4.80M$-837.58K$5.21M$4.89M
High Forecast$-20.57M$-11.56M$-1.53M$7.48M$10.52M$5.17M
Low Forecast$-22.78M$-12.22M$-8.07M$-9.16M$-4.32M$4.67M
Surprise %175.90%179.56%1350.61%---

TLSI Forecast FAQ

Is TriSalus Life Sciences stock a buy?

TriSalus Life Sciences stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that TriSalus Life Sciences is a favorable investment for most analysts.

What is TriSalus Life Sciences's price target?

TriSalus Life Sciences's price target, set by 4 Wall Street analysts, averages $11 over the next 12 months. The price target range spans from $8 at the low end to $12 at the high end, suggesting a potential 211.61% change from the previous closing price of $3.53.

How does TriSalus Life Sciences stock forecast compare to its benchmarks?

TriSalus Life Sciences's stock forecast shows a 211.61% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (9.18%).

What is the breakdown of analyst ratings for TriSalus Life Sciences over the past three months?

  • November 2026: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is TriSalus Life Sciences’s EPS forecast?

TriSalus Life Sciences's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.32, marking a -82.61% decrease from the reported $-1.84 in 2025. Estimates for the following years are $0.19 in 2027, and $0.52 in 2028.

What is TriSalus Life Sciences’s revenue forecast?

TriSalus Life Sciences's average annual revenue forecast for its fiscal year ending in December 2026 is $68.26M, reflecting a 51.19% increase from the reported $45.15M in 2025. The forecast for 2027 is $94.14M, and $117.21M for 2028.

What is TriSalus Life Sciences’s net income forecast?

TriSalus Life Sciences's net income forecast for the fiscal year ending in December 2026 stands at $-838K, representing a -98.80% decrease from the reported $-69.69M in 2025. Projections indicate $5.21M in 2027, and $4.89M in 2028.